Evidence map›Paper›PMID 38721371›Full record

ArticleACS catalysis2024

Electric Fields Are a Key Determinant of Carbapenemase Activity in Class A β-Lactamases.

Hira Jabeen, Michael Beer, James Spencer, Marc W van der Kamp, H Adrian Bunzel, Adrian J Mulholland

Abstract read
In one paragraph

Article in ACS catalysis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. The Discovery ofACS catalysis · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hira JabeenCentre for Computational Chemistry, School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.ORCID https://orcid.org/0009-0005-0883-803X
Michael BeerCentre for Computational Chemistry, School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-3879-3339
James SpencerSchool of Cellular and Molecular Medicine, University of Bristol, BS8 1TD Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-4602-0571
Marc W van der KampCentre for Computational Chemistry, School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.ORCID https://orcid.org/0000-0002-8060-3359
H Adrian BunzelCentre for Computational Chemistry, School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.ORCID https://orcid.org/0000-0001-6427-368X
Adrian J MulhollandCentre for Computational Chemistry, School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.ORCID https://orcid.org/0000-0003-1015-4567

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to antibiotics is a public health crisis. Although carbapenems are less susceptible to resistance than other β-lactam antibiotics, β-lactamases mediating resistance against these drugs are spreading. Here, we dissect the contributions of electric fields to carbapenemase activity in class A β-lactamases. We perform QM/MM molecular dynamics simulations of meropenem acyl-enzyme hydrolysis that correctly discriminate carbapenemases. Electric field analysis shows that active-site fields in the deacylation transition state and tetrahedral intermediate are important determinants of activity. The active-site fields identify several residues, some distal, that distinguish efficient carbapenemases. Our field analysis script (www.github.com/bunzela/FieldTools) may help in understanding and combating antibiotic resistance.

Identifiers

PMID38721371
PMCPMC11075022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.